PMID- 38435385 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20240305 IS - 2296-858X (Print) IS - 2296-858X (Electronic) IS - 2296-858X (Linking) VI - 11 DP - 2024 TI - Characteristic cytokine profile of the aqueous humor in eyes with congenital cataract and pre-existing posterior capsule dysfunction. PG - 1301588 LID - 10.3389/fmed.2024.1301588 [doi] LID - 1301588 AB - OBJECTIVES: To investigate the characteristic cytokine profile of the aqueous humor in eyes with congenital cataract and pre-existing posterior capsule dysfunction (PCD). METHODS: In this cross-sectional study, the enrolled eyes with congenital cataract and PCD were included in the PCD group, while those with an intact posterior capsule were included in the control group. Demographic data and biometric parameters were recorded. The levels of 17 inflammatory factors in the aqueous humor collected from the enrolled eyes were detected using Luminex xMAP technology, and intergroup differences in the collected data were analyzed. RESULTS: The PCD group comprised 41 eyes from 31 patients with congenital cataract and PCD, whereas the control group comprised 42 eyes from 27 patients with congenital cataract and an intact posterior capsule. Lens thickness was significantly thinner in the PCD group than in the control group. However, the levels of monocyte chemoattractant protein-1 (MCP-1), transforming growth factor-beta2 (TGF-beta2), and vascular endothelial growth factor (VEGF) were significantly higher in the PCD group than in the control group. Multivariate logistic regression confirmed that lens thickness and TGF-beta2 level were independent risk factors for PCD. CONCLUSION: A thinner lens thickness in eyes with congenital cataract and PCD could serve as a biometric feature of these eyes. The higher levels of MCP-1, TGF-beta2, and VEGF in eyes with PCD indicated a change in their intraocular inflammatory microenvironment, which possibly led to cataract progression. Lens thickness and TGF-beta2 level are independent risk factors for PCD. CI - Copyright (c) 2024 Zhao, Zhao, Zhang, Zhang, Wang, Li, Ding and Zhao. FAU - Zhao, Yinying AU - Zhao Y AD - The School of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou, Zhejiang, China. AD - National Clinical Research Center for Ocular Diseases, Wenzhou, Zhejiang, China. FAU - Zhao, Qihui AU - Zhao Q AD - The School of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou, Zhejiang, China. AD - National Clinical Research Center for Ocular Diseases, Wenzhou, Zhejiang, China. FAU - Zhang, Hongfang AU - Zhang H AD - The School of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou, Zhejiang, China. AD - National Clinical Research Center for Ocular Diseases, Wenzhou, Zhejiang, China. FAU - Zhang, Zhewen AU - Zhang Z AD - The School of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou, Zhejiang, China. AD - National Clinical Research Center for Ocular Diseases, Wenzhou, Zhejiang, China. FAU - Wang, Dandan AU - Wang D AD - The School of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou, Zhejiang, China. AD - National Clinical Research Center for Ocular Diseases, Wenzhou, Zhejiang, China. FAU - Li, Zhangliang AU - Li Z AD - The School of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou, Zhejiang, China. AD - National Clinical Research Center for Ocular Diseases, Wenzhou, Zhejiang, China. FAU - Ding, Xixia AU - Ding X AD - The School of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou, Zhejiang, China. AD - National Clinical Research Center for Ocular Diseases, Wenzhou, Zhejiang, China. FAU - Zhao, Yune AU - Zhao Y AD - The School of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou, Zhejiang, China. AD - National Clinical Research Center for Ocular Diseases, Wenzhou, Zhejiang, China. LA - eng PT - Journal Article DEP - 20240216 PL - Switzerland TA - Front Med (Lausanne) JT - Frontiers in medicine JID - 101648047 PMC - PMC10904641 OTO - NOTNLM OT - aqueous humor OT - congenital cataract OT - cytokine profile OT - inflammatory factors OT - posterior capsule dysfunction COIS- The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. EDAT- 2024/03/04 06:43 MHDA- 2024/03/04 06:44 PMCR- 2024/02/16 CRDT- 2024/03/04 04:59 PHST- 2023/09/25 00:00 [received] PHST- 2024/02/05 00:00 [accepted] PHST- 2024/03/04 06:44 [medline] PHST- 2024/03/04 06:43 [pubmed] PHST- 2024/03/04 04:59 [entrez] PHST- 2024/02/16 00:00 [pmc-release] AID - 10.3389/fmed.2024.1301588 [doi] PST - epublish SO - Front Med (Lausanne). 2024 Feb 16;11:1301588. doi: 10.3389/fmed.2024.1301588. eCollection 2024.